Veeva SystemsBSP:V2EE34 97 Market Cap is R$149,175 Mil as of Jul. 01, 2026. GuruFocus rates BSP:V2EE34 with a GF Score™ of 97/100 and a GF Value™ of R$49.24 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 695 Healthcare Providers & Services companies, Veeva Systems ranks better than 99.71% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Veeva Systems's share price for the quarter that ended in Apr. 2026 was R$25.77. Veeva Systems's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 4,893 Mil. Therefore, Veeva Systems's market cap for the quarter that ended in Apr. 2026 was R$126,097 Mil.
Veeva Systems's quarterly market cap
declined
from Oct. 2025 (R$258,112 Mil) to Jan. 2026 (R$177,254 Mil) and
declined
from Jan. 2026 (R$177,254 Mil) to Apr. 2026 (R$126,097 Mil).
Veeva Systems's annual market cap
increased
from Jan. 2024 (R$166,587 Mil) to Jan. 2025 (R$206,916 Mil) but then
declined
from Jan. 2025 (R$206,916 Mil) to Jan. 2026 (R$177,254 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Veeva Systems's Enterprise Value for Today is R$111,851 Mil.
Veeva Systems (BSP:V2EE34) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Veeva Systems Market Cap Related Terms
Veeva Systems Market Cap Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:V2EE34 vs BTSG, TEM, HQY: Market Cap Comparison
For the Health Information Services subindustry, Veeva Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Market Cap distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Veeva Systems's Market Cap for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (BSP:V2EE34) has a Market Cap of R$149,175 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Veeva Systems and its competitors. According to the industry distribution chart, Veeva Systems ranks #2 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 0.3%.
Is Veeva Systems' Market Cap too high?
Veeva Systems' current Market Cap is R$149,175 Mil. Based on the distribution chart, Veeva Systems ranks #2 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Market Cap compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #2 out of 695 companies for Market Cap. This places Veeva Systems in the top 0% of its industry — outperforming the majority of peers. The industry median Market Cap is 95.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.72, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Market Cap is R$149,175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$49.24, compared to a current price of R$30.58 — trading 37.9% below its estimated fair value. The current Market Cap is R$149,175 Mil. Veeva Systems' overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current Market Cap is R$149,175 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of R$30.58 is trading 37.9% below its estimated GF Value™ of R$49.24.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for BSP:V2EE34:
Market Cap: R$149,175 Mil
GF Value™: R$49.24 vs. price of R$30.58 (37.9% below fair value)
No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
97GF Score
Get the complete analysis for BSP:V2EE34
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:V2EE34 has been successfully added to your 
